BERLIN, Nov 7 — German vaccine maker BioNTech lowered its 2023 sales forecast for its Covid-19 vaccine yesterday to around €4 billion (RM19.94 billion).

DUSSELDORF, Aug 16 — German vaccine manufacturer Curevac is suing its competitor BioNTech for damages, accusing the top Covid-19 vaccine maker of patent infringement, reported the German News Agency (dpa).

ANKARA, Aug 27 — US biotechnology firm Moderna is suing rivals Pfizer and BioNTech for infringing patents central to its Covid-19 vaccine technology.

NEW YORK, June 26 — Pfizer Inc and BioNTech SE said on Saturday (June 25) that a booster dose of updated versions of their Covid-19 vaccine, modified specifically to combat the Omicron coronavirus variant, generated a higher immune response against that variant.

NEW YORK, Jan 26 — Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the Covid-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.

MOSCOW, Feb 2 — German company BioNTech plans to produce two billion doses of coronavirus vaccine in 2021 due to increased global demand, reported Sputnik news agency.

MANILA, Jan 14 — The Philippines' Food and Drug Administration (FDA) has authorised the emergency use of Pfizer Inc and BioNTech SE's Covid-19 vaccine, reported Xinhua news agency, quoting FDA head Enrique Domingo on Thursday.

KUALA LUMPUR, Dec 19 — Trade Minister Datuk Seri Mohamed Azmin Ali, on Saturday, said the country expects to receive the first batch of the Covid-19 vaccine jointly developed by Pfizer and BioNTech in February.

REUTERS, Dec 12 — The US Food and Drug Administration said it authorized the use of Pfizer Inc's Covid-19 vaccine on Friday, with the first inoculations expected within days, marking a turning point in the United States where the pandemic has killed more than 295,000 people.

BRUSSELS, Dec 2 — Pharmaceutical firms Pfizer and BioNTech, as well as their competitor Moderna, have filed applications for approval of their Covid-19 vaccines, reports Xinhua news agency according to the European Medicines Agency (EMA) on Tuesday.

Nov 19 — Final results from Pfizer Incorporated’s Covid-19 vaccine trial showed its shot had a 95per cent success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency US authorisation within days, it said on Wednesday.

RIO DE JANEIRO, Nov 10 — American drugmaker Pfizer and German pharmaceutical firm BioNTech will request Brazil's emergency use authorisation for a Covid-19 vaccine the two firms are jointly developing, Edson Moreira, the coordinator of the trials in the South American country, said on Monday.